Lars Køber

138.5k total citations · 28 hit papers
1.4k papers, 59.4k citations indexed

About

Lars Køber is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lars Køber has authored 1.4k papers receiving a total of 59.4k indexed citations (citations by other indexed papers that have themselves been cited), including 1.0k papers in Cardiology and Cardiovascular Medicine, 235 papers in Surgery and 198 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lars Køber's work include Cardiovascular Function and Risk Factors (336 papers), Heart Failure Treatment and Management (297 papers) and Cardiac Imaging and Diagnostics (196 papers). Lars Køber is often cited by papers focused on Cardiovascular Function and Risk Factors (336 papers), Heart Failure Treatment and Management (297 papers) and Cardiac Imaging and Diagnostics (196 papers). Lars Køber collaborates with scholars based in Denmark, United States and United Kingdom. Lars Køber's co-authors include Christian Torp‐Pedersen, Gunnar Gislason, John J.V. McMurray, Scott D. Solomon, Marc A. Pfeffer, Emil Loldrup Fosbøl, Aldo P. Maggioni, Eric J. Velazquez, Fredrik Folke and Morten Lock Hansen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Lars Køber

1.3k papers receiving 57.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

2015 1.7k citations Marc A. Pfeffer, Rafael Díaz et al. profile →
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

2003 1.7k citations Marc A. Pfeffer, John J.V. McMurray et al. profile →
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction

2004 1.5k citations John J.V. McMurray, Eric J. Velazquez et al. profile →
A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction

1995 1.3k citations Lars Køber, Christian Torp‐Pedersen et al. profile →
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

2019 1.1k citations Pardeep S. Jhund, Lars Køber et al. profile →
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients

2000 1.1k citations Lars Køber, Marc A. Pfeffer et al. profile →
Targeted Anticytokine Therapy in Patients With Chronic Heart Failure

2004 955 citations John J.V. McMurray, Karl Swedberg et al. Circulation profile →
Aliskiren, ALTITUDE, and the Implications for ATMOSPHERE

2012 909 citations John J.V. McMurray, Lars Køber et al. European Journal of Heart Failure profile →
Association of National Initiatives to Improve Cardiac Arrest Management With Rates of Bystander Intervention and Patient Survival After Out-of-Hospital Cardiac Arrest

2013 869 citations Mads Wissenberg, Freddy Lippert et al. profile →
Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

2012 846 citations John J.V. McMurray, Aldo P. Maggioni et al. profile →
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction

1999 738 citations Christian Torp‐Pedersen, Lars Køber et al. profile →
Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

2012 674 citations Jonas Bjerring Olesen, Gregory Y.H. Lip et al. profile →
Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation

2010 609 citations Morten Lock Hansen, Rikke Sørensen et al. profile →
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial

2015 586 citations Lars Køber et al. profile →
Increased Mortality after Dronedarone Therapy for Severe Heart Failure

2008 584 citations Lars Køber, Christian Torp‐Pedersen et al. profile →
Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

2005 525 citations Scott D. Solomon, John J.V. McMurray et al. profile →
Clinical Picture and Risk Prediction of Short-Term Mortality in Cardiogenic Shock

2015 494 citations Lars Køber et al. European Journal of Heart Failure profile →
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial

2012 473 citations Louise Lind Schierbeck, Lars Køber et al. profile →
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial

2013 447 citations Lars Køber, Faı̈ez Zannad et al. profile →
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

2011 418 citations Jan Skov Jensen, Lars Køber et al. profile →
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease

2016 299 citations Lars Køber, Aldo P. Maggioni et al. profile →
Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial

2021 289 citations Jesper Hastrup Svendsen, Søren Zöga Diederichsen et al. profile →
A Trial to Evaluate the Effect of the Sodium–Glucose Co-Transporter 2 Inhibitor Dapagliflozin on Morbidity and Mortality in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction (DAPA-HF)

2019 259 citations John J.V. McMurray, Lars Køber et al. European Journal of Heart Failure profile →
Bystander Efforts and 1-Year Outcomes in Out-of-Hospital Cardiac Arrest

2017 257 citations Kristian Kragholm, Mads Wissenberg et al. profile →
SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study

2021 163 citations Emil Loldrup Fosbøl, Gunnar Gislason et al. profile →
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF

2021 140 citations Pardeep S. Jhund, Mark C. Petrie et al. profile →
Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction

2021 130 citations Pardeep S. Jhund, Lars Køber et al. profile →
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox

2023 129 citations Jawad H. Butt, Mark C. Petrie et al. profile →

Peers

Countries citing papers authored by Lars Køber

Since Specialization

Citations

This map shows the geographic impact of Lars Køber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Køber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Køber more than expected).

Fields of papers citing papers by Lars Køber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Køber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Køber. The network helps show where Lars Køber may publish in the future.

Co-authorship network of co-authors of Lars Køber

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Køber. A scholar is included among the top collaborators of Lars Køber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Køber. Lars Køber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Accelerometer-measured physical activity in patients with heart failure and reduced ejection fraction: Determinants and relationship with patient-reported health status 2024 ·American Heart Journal ·(unknown), Massar Omar, (unknown), Caroline Kistorp, Christian Tuxen, Finn Gustafsson, Lars Køber, Mikael Kjær Poulsen, Jan Christian Brønd, Jacob Eifer Møller, Morten Schou, Jesper Rindom Jensen	0
2	Epicardial adipose tissue and subclinical incident atrial fibrillation as detected by continuous monitoring: a cardiac magnetic resonance imaging study 2024 ·The International Journal of Cardiovascular Imaging ·(unknown), Søren Zöga Diederichsen, Ketil Haugan, Axel Brandes, Claus Graff, Derk Krieger, Morten Olesen, Søren Højberg, Lars Køber, Niels Vejlstrup, Litten Bertelsen, Jesper Hastrup Svendsen	4
3	Mortality and rehospitalization after mitral valve surgery as a function of age and key comorbidities 2023 ·American Heart Journal ·Eva Havers‐Borgersen, Jawad H. Butt, Jarl Emanuel Strange, (unknown), Lars Køber, Emil Loldrup Fosbøl	6
4	Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy 2022 ·Circulation ·Amil M. Shah, Brian Claggett, Narayana Prasad, Guichu Li, (unknown), Karola Jering, Maja Čikeš, Attila Kovács, Wilfried Müllens, José Carlos Nicolau, Lars Køber, Peter van der Meer, Pardeep S. Jhund, Ghionul Ibram, Martin Lefkowitz, Yinong Zhou, Scott D. Solomon, Marc A. Pfeffer	32
5	Association Between Prescribed Ibuprofen and Severe COVID‐19 Infection: A Nationwide Register‐Based Cohort Study 2020 ·Clinical and Translational Science ·Kristian Kragholm, Thomas Alexander Gerds, Emil Loldrup Fosbøl, Mikkel Porsborg Andersen, Matthew Phelps, Jawad H. Butt, Lauge Østergaard, Casper N. Bang, Jannik Langtved Pallisgaard, Gunnar Gislason, Morten Schou, Lars Køber, Christian Torp‐Pedersen	24
6	Influenza Vaccine in Heart Failure 2019 ·Circulation ·Daniel Modin, Mads Emil Jørgensen, Gunnar Gislason, Jan Skov Jensen, Lars Køber, Brian Claggett, Sheila M. Hegde, Scott D. Solomon, Christian Torp‐Pedersen, Tor Biering‐Sørensen	105
7	Prevalence of Peripheral Artery Disease is Higher in Persons Living with HIV Compared to Uninfected Controls 2018 ·UCL Discovery (University College London) ·Andreas Dehlbæk Knudsen, Marco Gelpi, Shoaib Afzal, Andreas Ronit, Ashley Roen, Amanda Mocroft, Jens Lundgren, Børge G. Nordestgaard, Henrik Sillesen, (unknown), Lars Køber, Klaus F. Kofoed, Susanne Dam Nielsen	3
8	Electrocardiographic Preexcitation and Risk of Cardiovascular Morbidity and Mortality 2017 ·Circulation Arrhythmia and Electrophysiology ·Morten W. Skov, Peter Rasmussen, Jonas Ghouse, Steen Møller Hansen, Claus Graff, Morten S. Olesen, Adrian Pietersen, Christian Torp‐Pedersen, Stig Haunsø, Lars Køber, Jesper Hastrup Svendsen, Anders G. Holst, Jonas B. Nielsen	15
9	Survival After Out-of-Hospital Cardiac Arrest in Relation to Age and Early Identification of Patients With Minimal Chance of Long-Term Survival 2015 ·Circulation ·Mads Wissenberg, Fredrik Folke, Carolina Malta Hansen, Freddy Lippert, Kristian Kragholm, Bjarke Risgaard, Shahzleen Rajan, Lena Karlsson, Kathrine Bach Søndergaard, Steen Møller Hansen, Rikke Nørmark Mortensen, Peter Weeke, Erika Frischknecht Christensen, Søren Nielsen, Gunnar Gislason, Lars Køber, Christian Torp‐Pedersen	77
10	Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients Taking an Oral Anticoagulant 2014 ·Circulation ·Morten Lamberts, Gunnar Gislason, Gregory Y.H. Lip, Jens Flensted Lassen, Jonas Bjerring Olesen, Anders Pretzmann Mikkelsen, Rikke Sørensen, Lars Køber, Christian Torp‐Pedersen, Morten Lock Hansen	181
11	A systematic review on the safety and efficacy of percutaneous edge-to-edge mitral valve repair with the MitraClip system for high surgical risk candidates 2013 ·Heart ·Stine Munkholm-Larsen, Benjamin Wan, David H. Tian, (unknown), Mohammad Rahnavardi, Ulrik Dixen, Lars Køber, Ottavio Alfieri, Tristan D. Yan	39
12	Exercise Hemodynamics in Patients With and Without Diastolic Dysfunction and Preserved Ejection Fraction After Myocardial Infarction 2012 ·Circulation Heart Failure ·Mads J. Andersen, Mads Ersbøll, John Bro‐Jeppesen, Finn Gustafsson, Christian Hassager, Lars Køber, Barry A. Borlaug, Søren Boesgaard, (unknown), Jacob Eifer Møller	43
13	Parathyroid hormone and vitamin D—markers for cardiovascular and all cause mortality in heart failure 2011 ·European Journal of Heart Failure ·Louise Lind Schierbeck, (unknown), U. Bang, Gorm Boje Jensen, Lars Køber, Jens‐Erik Beck Jensen	114
14	Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction 2011 ·Circulation ·Anne‐Marie Schjerning Olsen, Emil Loldrup Fosbøl, Jesper Lindhardsen, Fredrik Folke, Mette Charlot, Christian Selmer, Morten Lamberts, Jonas Olesen, Lars Køber, Peter Riis Hansen, Christian Torp‐Pedersen, Gunnar Gislason	243
15	Clinical Implications of Electrocardiographic Left Ventricular Strain and Hypertrophy in Asymptomatic Patients With Aortic Stenosis 2011 ·Circulation ·Anders M. Greve, Kurt Boman, Christa Gohlke-Baerwolf, Y. Antero Kesäniemi, Christoph Nienaber, Simon Ray, Kenneth Egstrup, Anne B. Rossebø, Richard B. Devereux, Lars Køber, Ronnie Willenheimer, Kristian Wachtell	49
16	The Inter-Relationship of Diabetes and Left Ventricular Systolic Function on Outcome After High-Risk Myocardial Infarction 2010 ·European Journal of Heart Failure ·Amil M. Shah, Hajime Uno, Lars Køber, Eric J. Velazquez, Aldo P. Maggioni, Michael R. MacDonald, Mark C. Petrie, John J.V. McMurray, Robert M. Califf, Marc A. Pfeffer, Scott D. Solomon	39
17	Accuracy of a Heart Failure Diagnosis in Administrative Registers 2008 ·European Journal of Heart Failure ·Thomas Kümler, Gunnar Gislason, Vibeke Kirk, Morten Bay, Olav Wendelboe Nielsen, Lars Køber, Christian Torp‐Pedersen	218
18	Right Ventricular Dysfunction as an Independent Predictor of Short- and Long-Term Mortality in Patients with Heart Failure 2007 ·European Journal of Heart Failure ·Jesper Kjærgaard, Dilek Akkan, Kasper Iversen, Lars Køber, Christian Torp‐Pedersen, Christian Hassager	197
19	A Systematic Review: Effect of Angiotensin Converting Enzyme Inhibition on Left Ventricular Volumes and Ejection Fraction in Patients with a Myocardial Infarction and in Patients with Left Ventricular Dysfunction 2006 ·European Journal of Heart Failure ·Jawdat Abdulla, Simona Barlera, Roberto Latini, Lars Kjøller‐Hansen, Peter Søgaard, Erik Christensen, Lars Køber, Christian Torp‐Pedersen	41
20	Previously Known and Newly Diagnosed Atrial Fibrillation: A Major Risk Indicator After a Myocardial Infarction Complicated by Heart Failure or Left Ventricular Dysfunction 2006 ·European Journal of Heart Failure ·Lars Køber, Karl Swedberg, John J.V. McMurray, Marc A. Pfeffer, Eric J. Velazquez, Rafael Díaz, Aldo P. Maggioni, Mareev VIu, Grzegorz Opolski, Frans Van de Werf, Faı̈ez Zannad, Georg Ertl, Scott D. Solomon, Steven L. Zelenkofske, Jean‐Lucien Rouleau, Jeffrey D. Leimberger, Robert M. Califf	102

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact